$ELTP 4 SEC Filings

Filed On	Filing
19 Oct 2026	Form 4: Dash Barry H, Director Bought 100,000 shares ($26K)
10 Sep 2026	Form 4: Dash Barry H, Director Bought 30,000 shares ($8.61K)
13 Jan 2026	Form 4: Plassche Douglas, EVP Operations Received 2,500,000 shares by exercise or conversion ($75K)
03 Oct 2025	Form 4: Plassche Douglas, EVP Operations Sold 800,000 shares ($499K)
26 Aug 2025	Form 4: Elite Pharmaceuticals Inc /NV/, EVP Operations Sold 500,000 shares ($262K) · Received 2,500,000 shares by exercise or conversion ($75K)
25 Jul 2025	Form 4: Kirkov Kirko, Chief Commercial Officer Bought 16,366 shares ($9.64K)
10 Jul 2025	Form 4: Plassche Douglas, EVP Operations Sold 200,000 shares ($116K)
08 Jul 2025	Form 4: Plassche Douglas, EVP Operations Received 2,500,000 shares by exercise or conversion ($75K)
28 Oct 2024	Form 4: Plassche Douglas, SVP of Operations Sold 800,000 shares ($392K) · Sold 333,932 shares ($170K)
02 Apr 2024	Form 4: Hakim Nasrat A, Director Received 49,534,368 shares as a grant or award
29 Dec 2023	Form 4: Hakim Nasrat A, Director Received 2,223,147 shares as a grant or award ($153K)
27 Nov 2023	Form 4: Whitnell Jeffrey A, Director Received 547,657 shares as a grant or award ($20K)
27 Nov 2023	Form 4: Caskey Davis S, Director Received 547,657 shares as a grant or award ($20K)
27 Nov 2023	Form 4: Dash Barry H, Director Received 547,657 shares as a grant or award ($20K)
26 Jun 2023	Form 4: Plassche Douglas, Executive VP Operations Granted 7,500,000 Options ($225K)
14 Nov 2022	Form 4: Kirkov Kirko, Chief Commercial Officer Granted 3,000,000 Options ($105K)
29 Aug 2022	Form 4: Caskey Davis S, Director Received 459,536 shares as a grant or award ($20K)
29 Aug 2022	Form 4: Whitnell Jeffrey A, Director Received 459,536 shares as a grant or award ($20K)
29 Aug 2022	Form 4: Dash Barry H, Director Received 459,536 shares as a grant or award ($20K)
07 Jul 2022	Form 4: Chen Robert C J, CFO, Secretary, Treasurer Granted 900,000 Options ($36K)

Comments